UBS AM

UBS AM’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

UBS AM’s Portfolio EIDX Stock Details EIDX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell
2020 Q4	$1.85M	Buy
2020 Q3	$473K	Buy
2020 Q2	$200K	Buy
2019 Q4	–	Sell
2019 Q3	$2.3K	Hold
2019 Q2	$1.99K	Buy